ANNALS OF ONCOLOGY-期刊论坛，投稿经验-MedSci.cn

[GetPortalCommentsPageByObjectIdResponse(id=569761, encodeId=f286569e6195, content=那也不错了啊！Dr_Hemis_AI 2019-03-09 发表:: 审稿意见很好，基本就是小修。 2月11再次上传修改稿， 3月8号接受。一切很顺利。之前投稿Journal of Clinical Oncology，审稿人提了一堆与研究无关的审稿意见。于是索性原稿投Annals of Oncology。所幸中了。 Dr_Hemis_AI 2019-03-09 00:00:00 发表: 审稿意见很好，基本就是小修。 2月11再次上传修改稿， 3月8号接受。一切很顺利。之前投稿Journal of Clinical Oncology，审稿人提了一堆与研究无关的审稿意见。于是索性原稿投Annals of Oncology。所幸中了。 , beContent=Dr_Hemis_AI 2019-03-09 发表:: 审稿意见很好，基本就是小修。 2月11再次上传修改稿， 3月8号接受。一切很顺利。之前投稿Journal of Clinical Oncology，审稿人提了一堆与研究无关的审稿意见。于是索性原稿投Annals of Oncology。所幸中了。 , objectType=tool_impact_factor, channel=null, level=null, likeNumber=263, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://cdnapi.center.medsci.cn/medsci/head/2017/08/15/af911bdd940ac5430dfecaae1ba3bfff.jpg, createdBy=75e41936661, createdName=sunliang, createdTime=Fri Apr 19 00:00:00 CST 2019, time=2019-04-19, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=586765, encodeId=c2d7586e65c3, content=2月3号修回。 3月16号接受。 187****8818暂无昵称 2020-01-08 发表:: 接收率：约25% 审稿时间：约1个月有一篇7天后被拒，没送审。另外一篇12月12投稿。 1月8号有反馈。目前小修。187****8818暂无昵称 2020-01-08 00:00:00 发表: 有一篇7天后被拒，没送审。另外一篇12月12投稿。 1月8号有反馈。目前小修。, beContent=187****8818暂无昵称 2020-01-08 发表:: 接收率：约25% 审稿时间：约1个月有一篇7天后被拒，没送审。另外一篇12月12投稿。 1月8号有反馈。目前小修。, objectType=tool_impact_factor, channel=null, level=null, likeNumber=262, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=d0805157601, createdName=146academ18暂无昵称, createdTime=Tue Mar 17 00:00:00 CST 2020, time=2020-03-17, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2148450, encodeId=4ab0214845062, content=审稿速度:3.0 | 投稿命中率:25.0 偏重的研究方向：肿瘤 经验分享：为什么现在首页打不开, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=167, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=1f218759120, createdName=ms3000001014938846, createdTime=Mon Jul 17 14:52:01 CST 2023, time=2023-07-17, status=1, ipAttribution=天津), GetPortalCommentsPageByObjectIdResponse(id=567781, encodeId=039656e78139, content=为什么现在杂志投稿连接打不开, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=307, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=d09f88778, createdName=wwei0125, createdTime=Thu Mar 07 19:24:00 CST 2019, time=2019-03-07, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=881986, encodeId=082b8819863d, content=不接受非邀稿的综述，两个小时秒拒, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=347, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://wx.qlogo.cn/mmopen/vi_32/Q0gbVISGnicok3a1pkk9eJjGUG8JvN5oCPbpgzZ0gK3jcOMeNDmiajAUNfvf1vrSzgFDoKdibR60zVzdpBxBOs9cw/0, createdBy=83c82193682, createdName=krygios, createdTime=Wed Sep 02 07:27:09 CST 2020, time=2020-09-02, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=587926, encodeId=81dd58e92619, content=大家有没有注意自己的投稿状态呀？Under review指的是还在编辑手上评估吗？还是说和其他期刊的Under Review 一样，已经送外审了呢？知道投稿状态的请教一下。谢谢。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=372, replyNumber=6, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=10ee2307349, createdName=1221c8e5m44(暂无昵称), createdTime=Wed Apr 01 00:00:00 CST 2020, time=2020-04-01, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1086767, encodeId=c65a1086e6759, content=什么是letter?, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=215, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20220301/3a52d3952dde49019f1e000bb5c41d1c/0a0eb7959bb14fcd87745f869bee3c33.jpg, createdBy=46f32239729, createdName=Mia, createdTime=Tue Dec 28 14:52:47 CST 2021, time=2021-12-28, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1086768, encodeId=b5e91086e6834, content=什么是comment？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=206, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20220301/3a52d3952dde49019f1e000bb5c41d1c/0a0eb7959bb14fcd87745f869bee3c33.jpg, createdBy=46f32239729, createdName=Mia, createdTime=Mon Dec 27 14:52:47 CST 2021, time=2021-12-27, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=900668, encodeId=0036900668be, content=接受基础文章吗, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=347, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/Q0j4TwGTfTJYzYwLeVAa37S42RVHfvKoq2bVFKkmib0QsicMXN2gLlLkOrvs7ndVfL4IosDDSX4DibicGUhGVgmlYA/132, createdBy=b99e2511660, createdName=大医wgz, createdTime=Fri Nov 20 00:36:40 CST 2020, time=2020-11-20, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=885313, encodeId=22e1885313e9, content=想问一下under review 是送审了吗？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=343, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f6ed5410581, createdName=ms6000001824280640, createdTime=Mon Sep 14 23:14:22 CST 2020, time=2020-09-14, status=1, ipAttribution=)]

2019-04-19 sunliang

那也不错了啊！Dr_Hemis_AI 2019-03-09 发表::
审稿意见很好，基本就是小修。 2月11再次上传修改稿， 3月8号接受。一切很顺利。之前投稿Journal of Clinical Oncology，审稿人提了一堆与研究无关的审稿意见。于是索性原稿投Annals of Oncology。所幸中了。 Dr_Hemis_AI 2019-03-09 00:00:00 发表:
审稿意见很好，基本就是小修。 2月11再次上传修改稿， 3月8号接受。一切很顺利。之前投稿Journal of Clinical Oncology，审稿人提了一堆与研究无关的审稿意见。于是索性原稿投Annals of Oncology。所幸中了。

Dr_Hemis_AI 2019-03-09 发表:: 审稿意见很好，基本就是小修。 2月11再次上传修改稿， 3月8号接受。一切很顺利。之前投稿Journal of Clinical Oncology，审稿人提了一堆与研究无关的审稿意见。于是索性原稿投Annals of Oncology。所幸中了。

263 1

展开1条回复

[GetPortalCommentsPageByObjectIdResponse(id=569761, encodeId=f286569e6195, content=那也不错了啊！Dr_Hemis_AI 2019-03-09 发表:: 审稿意见很好，基本就是小修。 2月11再次上传修改稿， 3月8号接受。一切很顺利。之前投稿Journal of Clinical Oncology，审稿人提了一堆与研究无关的审稿意见。于是索性原稿投Annals of Oncology。所幸中了。 Dr_Hemis_AI 2019-03-09 00:00:00 发表: 审稿意见很好，基本就是小修。 2月11再次上传修改稿， 3月8号接受。一切很顺利。之前投稿Journal of Clinical Oncology，审稿人提了一堆与研究无关的审稿意见。于是索性原稿投Annals of Oncology。所幸中了。 , beContent=Dr_Hemis_AI 2019-03-09 发表:: 审稿意见很好，基本就是小修。 2月11再次上传修改稿， 3月8号接受。一切很顺利。之前投稿Journal of Clinical Oncology，审稿人提了一堆与研究无关的审稿意见。于是索性原稿投Annals of Oncology。所幸中了。 , objectType=tool_impact_factor, channel=null, level=null, likeNumber=263, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://cdnapi.center.medsci.cn/medsci/head/2017/08/15/af911bdd940ac5430dfecaae1ba3bfff.jpg, createdBy=75e41936661, createdName=sunliang, createdTime=Fri Apr 19 00:00:00 CST 2019, time=2019-04-19, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=586765, encodeId=c2d7586e65c3, content=2月3号修回。 3月16号接受。 187****8818暂无昵称 2020-01-08 发表:: 接收率：约25% 审稿时间：约1个月有一篇7天后被拒，没送审。另外一篇12月12投稿。 1月8号有反馈。目前小修。187****8818暂无昵称 2020-01-08 00:00:00 发表: 有一篇7天后被拒，没送审。另外一篇12月12投稿。 1月8号有反馈。目前小修。, beContent=187****8818暂无昵称 2020-01-08 发表:: 接收率：约25% 审稿时间：约1个月有一篇7天后被拒，没送审。另外一篇12月12投稿。 1月8号有反馈。目前小修。, objectType=tool_impact_factor, channel=null, level=null, likeNumber=262, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=d0805157601, createdName=146academ18暂无昵称, createdTime=Tue Mar 17 00:00:00 CST 2020, time=2020-03-17, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2148450, encodeId=4ab0214845062, content=审稿速度:3.0 | 投稿命中率:25.0 偏重的研究方向：肿瘤 经验分享：为什么现在首页打不开, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=167, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=1f218759120, createdName=ms3000001014938846, createdTime=Mon Jul 17 14:52:01 CST 2023, time=2023-07-17, status=1, ipAttribution=天津), GetPortalCommentsPageByObjectIdResponse(id=567781, encodeId=039656e78139, content=为什么现在杂志投稿连接打不开, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=307, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=d09f88778, createdName=wwei0125, createdTime=Thu Mar 07 19:24:00 CST 2019, time=2019-03-07, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=881986, encodeId=082b8819863d, content=不接受非邀稿的综述，两个小时秒拒, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=347, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://wx.qlogo.cn/mmopen/vi_32/Q0gbVISGnicok3a1pkk9eJjGUG8JvN5oCPbpgzZ0gK3jcOMeNDmiajAUNfvf1vrSzgFDoKdibR60zVzdpBxBOs9cw/0, createdBy=83c82193682, createdName=krygios, createdTime=Wed Sep 02 07:27:09 CST 2020, time=2020-09-02, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=587926, encodeId=81dd58e92619, content=大家有没有注意自己的投稿状态呀？Under review指的是还在编辑手上评估吗？还是说和其他期刊的Under Review 一样，已经送外审了呢？知道投稿状态的请教一下。谢谢。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=372, replyNumber=6, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=10ee2307349, createdName=1221c8e5m44(暂无昵称), createdTime=Wed Apr 01 00:00:00 CST 2020, time=2020-04-01, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1086767, encodeId=c65a1086e6759, content=什么是letter?, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=215, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20220301/3a52d3952dde49019f1e000bb5c41d1c/0a0eb7959bb14fcd87745f869bee3c33.jpg, createdBy=46f32239729, createdName=Mia, createdTime=Tue Dec 28 14:52:47 CST 2021, time=2021-12-28, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1086768, encodeId=b5e91086e6834, content=什么是comment？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=206, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20220301/3a52d3952dde49019f1e000bb5c41d1c/0a0eb7959bb14fcd87745f869bee3c33.jpg, createdBy=46f32239729, createdName=Mia, createdTime=Mon Dec 27 14:52:47 CST 2021, time=2021-12-27, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=900668, encodeId=0036900668be, content=接受基础文章吗, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=347, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/Q0j4TwGTfTJYzYwLeVAa37S42RVHfvKoq2bVFKkmib0QsicMXN2gLlLkOrvs7ndVfL4IosDDSX4DibicGUhGVgmlYA/132, createdBy=b99e2511660, createdName=大医wgz, createdTime=Fri Nov 20 00:36:40 CST 2020, time=2020-11-20, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=885313, encodeId=22e1885313e9, content=想问一下under review 是送审了吗？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=343, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f6ed5410581, createdName=ms6000001824280640, createdTime=Mon Sep 14 23:14:22 CST 2020, time=2020-09-14, status=1, ipAttribution=)]

2020-03-17 146academ18暂无昵称

2月3号修回。 3月16号接受。 187****8818暂无昵称 2020-01-08 发表::
接收率：约25% 审稿时间：约1个月有一篇7天后被拒，没送审。另外一篇12月12投稿。 1月8号有反馈。目前小修。187****8818暂无昵称 2020-01-08 00:00:00 发表:
有一篇7天后被拒，没送审。另外一篇12月12投稿。 1月8号有反馈。目前小修。

187****8818暂无昵称 2020-01-08 发表:: 接收率：约25% 审稿时间：约1个月有一篇7天后被拒，没送审。另外一篇12月12投稿。 1月8号有反馈。目前小修。

262 1

展开1条回复

[GetPortalCommentsPageByObjectIdResponse(id=569761, encodeId=f286569e6195, content=那也不错了啊！Dr_Hemis_AI 2019-03-09 发表:: 审稿意见很好，基本就是小修。 2月11再次上传修改稿， 3月8号接受。一切很顺利。之前投稿Journal of Clinical Oncology，审稿人提了一堆与研究无关的审稿意见。于是索性原稿投Annals of Oncology。所幸中了。 Dr_Hemis_AI 2019-03-09 00:00:00 发表: 审稿意见很好，基本就是小修。 2月11再次上传修改稿， 3月8号接受。一切很顺利。之前投稿Journal of Clinical Oncology，审稿人提了一堆与研究无关的审稿意见。于是索性原稿投Annals of Oncology。所幸中了。 , beContent=Dr_Hemis_AI 2019-03-09 发表:: 审稿意见很好，基本就是小修。 2月11再次上传修改稿， 3月8号接受。一切很顺利。之前投稿Journal of Clinical Oncology，审稿人提了一堆与研究无关的审稿意见。于是索性原稿投Annals of Oncology。所幸中了。 , objectType=tool_impact_factor, channel=null, level=null, likeNumber=263, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://cdnapi.center.medsci.cn/medsci/head/2017/08/15/af911bdd940ac5430dfecaae1ba3bfff.jpg, createdBy=75e41936661, createdName=sunliang, createdTime=Fri Apr 19 00:00:00 CST 2019, time=2019-04-19, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=586765, encodeId=c2d7586e65c3, content=2月3号修回。 3月16号接受。 187****8818暂无昵称 2020-01-08 发表:: 接收率：约25% 审稿时间：约1个月有一篇7天后被拒，没送审。另外一篇12月12投稿。 1月8号有反馈。目前小修。187****8818暂无昵称 2020-01-08 00:00:00 发表: 有一篇7天后被拒，没送审。另外一篇12月12投稿。 1月8号有反馈。目前小修。, beContent=187****8818暂无昵称 2020-01-08 发表:: 接收率：约25% 审稿时间：约1个月有一篇7天后被拒，没送审。另外一篇12月12投稿。 1月8号有反馈。目前小修。, objectType=tool_impact_factor, channel=null, level=null, likeNumber=262, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=d0805157601, createdName=146academ18暂无昵称, createdTime=Tue Mar 17 00:00:00 CST 2020, time=2020-03-17, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2148450, encodeId=4ab0214845062, content=审稿速度:3.0 | 投稿命中率:25.0 偏重的研究方向：肿瘤 经验分享：为什么现在首页打不开, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=167, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=1f218759120, createdName=ms3000001014938846, createdTime=Mon Jul 17 14:52:01 CST 2023, time=2023-07-17, status=1, ipAttribution=天津), GetPortalCommentsPageByObjectIdResponse(id=567781, encodeId=039656e78139, content=为什么现在杂志投稿连接打不开, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=307, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=d09f88778, createdName=wwei0125, createdTime=Thu Mar 07 19:24:00 CST 2019, time=2019-03-07, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=881986, encodeId=082b8819863d, content=不接受非邀稿的综述，两个小时秒拒, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=347, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://wx.qlogo.cn/mmopen/vi_32/Q0gbVISGnicok3a1pkk9eJjGUG8JvN5oCPbpgzZ0gK3jcOMeNDmiajAUNfvf1vrSzgFDoKdibR60zVzdpBxBOs9cw/0, createdBy=83c82193682, createdName=krygios, createdTime=Wed Sep 02 07:27:09 CST 2020, time=2020-09-02, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=587926, encodeId=81dd58e92619, content=大家有没有注意自己的投稿状态呀？Under review指的是还在编辑手上评估吗？还是说和其他期刊的Under Review 一样，已经送外审了呢？知道投稿状态的请教一下。谢谢。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=372, replyNumber=6, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=10ee2307349, createdName=1221c8e5m44(暂无昵称), createdTime=Wed Apr 01 00:00:00 CST 2020, time=2020-04-01, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1086767, encodeId=c65a1086e6759, content=什么是letter?, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=215, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20220301/3a52d3952dde49019f1e000bb5c41d1c/0a0eb7959bb14fcd87745f869bee3c33.jpg, createdBy=46f32239729, createdName=Mia, createdTime=Tue Dec 28 14:52:47 CST 2021, time=2021-12-28, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1086768, encodeId=b5e91086e6834, content=什么是comment？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=206, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20220301/3a52d3952dde49019f1e000bb5c41d1c/0a0eb7959bb14fcd87745f869bee3c33.jpg, createdBy=46f32239729, createdName=Mia, createdTime=Mon Dec 27 14:52:47 CST 2021, time=2021-12-27, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=900668, encodeId=0036900668be, content=接受基础文章吗, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=347, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/Q0j4TwGTfTJYzYwLeVAa37S42RVHfvKoq2bVFKkmib0QsicMXN2gLlLkOrvs7ndVfL4IosDDSX4DibicGUhGVgmlYA/132, createdBy=b99e2511660, createdName=大医wgz, createdTime=Fri Nov 20 00:36:40 CST 2020, time=2020-11-20, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=885313, encodeId=22e1885313e9, content=想问一下under review 是送审了吗？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=343, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f6ed5410581, createdName=ms6000001824280640, createdTime=Mon Sep 14 23:14:22 CST 2020, time=2020-09-14, status=1, ipAttribution=)]

2023-07-17 ms3000001014938846 来自天津

审稿速度:3.0 | 投稿命中率:25.0
偏重的研究方向：肿瘤
经验分享：为什么现在首页打不开

167 0

[GetPortalCommentsPageByObjectIdResponse(id=569761, encodeId=f286569e6195, content=那也不错了啊！Dr_Hemis_AI 2019-03-09 发表:: 审稿意见很好，基本就是小修。 2月11再次上传修改稿， 3月8号接受。一切很顺利。之前投稿Journal of Clinical Oncology，审稿人提了一堆与研究无关的审稿意见。于是索性原稿投Annals of Oncology。所幸中了。 Dr_Hemis_AI 2019-03-09 00:00:00 发表: 审稿意见很好，基本就是小修。 2月11再次上传修改稿， 3月8号接受。一切很顺利。之前投稿Journal of Clinical Oncology，审稿人提了一堆与研究无关的审稿意见。于是索性原稿投Annals of Oncology。所幸中了。 , beContent=Dr_Hemis_AI 2019-03-09 发表:: 审稿意见很好，基本就是小修。 2月11再次上传修改稿， 3月8号接受。一切很顺利。之前投稿Journal of Clinical Oncology，审稿人提了一堆与研究无关的审稿意见。于是索性原稿投Annals of Oncology。所幸中了。 , objectType=tool_impact_factor, channel=null, level=null, likeNumber=263, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://cdnapi.center.medsci.cn/medsci/head/2017/08/15/af911bdd940ac5430dfecaae1ba3bfff.jpg, createdBy=75e41936661, createdName=sunliang, createdTime=Fri Apr 19 00:00:00 CST 2019, time=2019-04-19, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=586765, encodeId=c2d7586e65c3, content=2月3号修回。 3月16号接受。 187****8818暂无昵称 2020-01-08 发表:: 接收率：约25% 审稿时间：约1个月有一篇7天后被拒，没送审。另外一篇12月12投稿。 1月8号有反馈。目前小修。187****8818暂无昵称 2020-01-08 00:00:00 发表: 有一篇7天后被拒，没送审。另外一篇12月12投稿。 1月8号有反馈。目前小修。, beContent=187****8818暂无昵称 2020-01-08 发表:: 接收率：约25% 审稿时间：约1个月有一篇7天后被拒，没送审。另外一篇12月12投稿。 1月8号有反馈。目前小修。, objectType=tool_impact_factor, channel=null, level=null, likeNumber=262, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=d0805157601, createdName=146academ18暂无昵称, createdTime=Tue Mar 17 00:00:00 CST 2020, time=2020-03-17, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2148450, encodeId=4ab0214845062, content=审稿速度:3.0 | 投稿命中率:25.0 偏重的研究方向：肿瘤 经验分享：为什么现在首页打不开, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=167, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=1f218759120, createdName=ms3000001014938846, createdTime=Mon Jul 17 14:52:01 CST 2023, time=2023-07-17, status=1, ipAttribution=天津), GetPortalCommentsPageByObjectIdResponse(id=567781, encodeId=039656e78139, content=为什么现在杂志投稿连接打不开, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=307, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=d09f88778, createdName=wwei0125, createdTime=Thu Mar 07 19:24:00 CST 2019, time=2019-03-07, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=881986, encodeId=082b8819863d, content=不接受非邀稿的综述，两个小时秒拒, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=347, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://wx.qlogo.cn/mmopen/vi_32/Q0gbVISGnicok3a1pkk9eJjGUG8JvN5oCPbpgzZ0gK3jcOMeNDmiajAUNfvf1vrSzgFDoKdibR60zVzdpBxBOs9cw/0, createdBy=83c82193682, createdName=krygios, createdTime=Wed Sep 02 07:27:09 CST 2020, time=2020-09-02, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=587926, encodeId=81dd58e92619, content=大家有没有注意自己的投稿状态呀？Under review指的是还在编辑手上评估吗？还是说和其他期刊的Under Review 一样，已经送外审了呢？知道投稿状态的请教一下。谢谢。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=372, replyNumber=6, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=10ee2307349, createdName=1221c8e5m44(暂无昵称), createdTime=Wed Apr 01 00:00:00 CST 2020, time=2020-04-01, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1086767, encodeId=c65a1086e6759, content=什么是letter?, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=215, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20220301/3a52d3952dde49019f1e000bb5c41d1c/0a0eb7959bb14fcd87745f869bee3c33.jpg, createdBy=46f32239729, createdName=Mia, createdTime=Tue Dec 28 14:52:47 CST 2021, time=2021-12-28, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1086768, encodeId=b5e91086e6834, content=什么是comment？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=206, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20220301/3a52d3952dde49019f1e000bb5c41d1c/0a0eb7959bb14fcd87745f869bee3c33.jpg, createdBy=46f32239729, createdName=Mia, createdTime=Mon Dec 27 14:52:47 CST 2021, time=2021-12-27, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=900668, encodeId=0036900668be, content=接受基础文章吗, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=347, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/Q0j4TwGTfTJYzYwLeVAa37S42RVHfvKoq2bVFKkmib0QsicMXN2gLlLkOrvs7ndVfL4IosDDSX4DibicGUhGVgmlYA/132, createdBy=b99e2511660, createdName=大医wgz, createdTime=Fri Nov 20 00:36:40 CST 2020, time=2020-11-20, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=885313, encodeId=22e1885313e9, content=想问一下under review 是送审了吗？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=343, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f6ed5410581, createdName=ms6000001824280640, createdTime=Mon Sep 14 23:14:22 CST 2020, time=2020-09-14, status=1, ipAttribution=)]

2019-03-07 wwei0125

为什么现在杂志投稿连接打不开

307 1

展开1条回复

[GetPortalCommentsPageByObjectIdResponse(id=569761, encodeId=f286569e6195, content=那也不错了啊！Dr_Hemis_AI 2019-03-09 发表:: 审稿意见很好，基本就是小修。 2月11再次上传修改稿， 3月8号接受。一切很顺利。之前投稿Journal of Clinical Oncology，审稿人提了一堆与研究无关的审稿意见。于是索性原稿投Annals of Oncology。所幸中了。 Dr_Hemis_AI 2019-03-09 00:00:00 发表: 审稿意见很好，基本就是小修。 2月11再次上传修改稿， 3月8号接受。一切很顺利。之前投稿Journal of Clinical Oncology，审稿人提了一堆与研究无关的审稿意见。于是索性原稿投Annals of Oncology。所幸中了。 , beContent=Dr_Hemis_AI 2019-03-09 发表:: 审稿意见很好，基本就是小修。 2月11再次上传修改稿， 3月8号接受。一切很顺利。之前投稿Journal of Clinical Oncology，审稿人提了一堆与研究无关的审稿意见。于是索性原稿投Annals of Oncology。所幸中了。 , objectType=tool_impact_factor, channel=null, level=null, likeNumber=263, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://cdnapi.center.medsci.cn/medsci/head/2017/08/15/af911bdd940ac5430dfecaae1ba3bfff.jpg, createdBy=75e41936661, createdName=sunliang, createdTime=Fri Apr 19 00:00:00 CST 2019, time=2019-04-19, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=586765, encodeId=c2d7586e65c3, content=2月3号修回。 3月16号接受。 187****8818暂无昵称 2020-01-08 发表:: 接收率：约25% 审稿时间：约1个月有一篇7天后被拒，没送审。另外一篇12月12投稿。 1月8号有反馈。目前小修。187****8818暂无昵称 2020-01-08 00:00:00 发表: 有一篇7天后被拒，没送审。另外一篇12月12投稿。 1月8号有反馈。目前小修。, beContent=187****8818暂无昵称 2020-01-08 发表:: 接收率：约25% 审稿时间：约1个月有一篇7天后被拒，没送审。另外一篇12月12投稿。 1月8号有反馈。目前小修。, objectType=tool_impact_factor, channel=null, level=null, likeNumber=262, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=d0805157601, createdName=146academ18暂无昵称, createdTime=Tue Mar 17 00:00:00 CST 2020, time=2020-03-17, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2148450, encodeId=4ab0214845062, content=审稿速度:3.0 | 投稿命中率:25.0 偏重的研究方向：肿瘤 经验分享：为什么现在首页打不开, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=167, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=1f218759120, createdName=ms3000001014938846, createdTime=Mon Jul 17 14:52:01 CST 2023, time=2023-07-17, status=1, ipAttribution=天津), GetPortalCommentsPageByObjectIdResponse(id=567781, encodeId=039656e78139, content=为什么现在杂志投稿连接打不开, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=307, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=d09f88778, createdName=wwei0125, createdTime=Thu Mar 07 19:24:00 CST 2019, time=2019-03-07, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=881986, encodeId=082b8819863d, content=不接受非邀稿的综述，两个小时秒拒, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=347, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://wx.qlogo.cn/mmopen/vi_32/Q0gbVISGnicok3a1pkk9eJjGUG8JvN5oCPbpgzZ0gK3jcOMeNDmiajAUNfvf1vrSzgFDoKdibR60zVzdpBxBOs9cw/0, createdBy=83c82193682, createdName=krygios, createdTime=Wed Sep 02 07:27:09 CST 2020, time=2020-09-02, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=587926, encodeId=81dd58e92619, content=大家有没有注意自己的投稿状态呀？Under review指的是还在编辑手上评估吗？还是说和其他期刊的Under Review 一样，已经送外审了呢？知道投稿状态的请教一下。谢谢。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=372, replyNumber=6, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=10ee2307349, createdName=1221c8e5m44(暂无昵称), createdTime=Wed Apr 01 00:00:00 CST 2020, time=2020-04-01, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1086767, encodeId=c65a1086e6759, content=什么是letter?, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=215, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20220301/3a52d3952dde49019f1e000bb5c41d1c/0a0eb7959bb14fcd87745f869bee3c33.jpg, createdBy=46f32239729, createdName=Mia, createdTime=Tue Dec 28 14:52:47 CST 2021, time=2021-12-28, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1086768, encodeId=b5e91086e6834, content=什么是comment？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=206, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20220301/3a52d3952dde49019f1e000bb5c41d1c/0a0eb7959bb14fcd87745f869bee3c33.jpg, createdBy=46f32239729, createdName=Mia, createdTime=Mon Dec 27 14:52:47 CST 2021, time=2021-12-27, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=900668, encodeId=0036900668be, content=接受基础文章吗, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=347, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/Q0j4TwGTfTJYzYwLeVAa37S42RVHfvKoq2bVFKkmib0QsicMXN2gLlLkOrvs7ndVfL4IosDDSX4DibicGUhGVgmlYA/132, createdBy=b99e2511660, createdName=大医wgz, createdTime=Fri Nov 20 00:36:40 CST 2020, time=2020-11-20, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=885313, encodeId=22e1885313e9, content=想问一下under review 是送审了吗？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=343, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f6ed5410581, createdName=ms6000001824280640, createdTime=Mon Sep 14 23:14:22 CST 2020, time=2020-09-14, status=1, ipAttribution=)]

2020-09-02 krygios

不接受非邀稿的综述，两个小时秒拒

347 1

展开1条回复

[GetPortalCommentsPageByObjectIdResponse(id=569761, encodeId=f286569e6195, content=那也不错了啊！Dr_Hemis_AI 2019-03-09 发表:: 审稿意见很好，基本就是小修。 2月11再次上传修改稿， 3月8号接受。一切很顺利。之前投稿Journal of Clinical Oncology，审稿人提了一堆与研究无关的审稿意见。于是索性原稿投Annals of Oncology。所幸中了。 Dr_Hemis_AI 2019-03-09 00:00:00 发表: 审稿意见很好，基本就是小修。 2月11再次上传修改稿， 3月8号接受。一切很顺利。之前投稿Journal of Clinical Oncology，审稿人提了一堆与研究无关的审稿意见。于是索性原稿投Annals of Oncology。所幸中了。 , beContent=Dr_Hemis_AI 2019-03-09 发表:: 审稿意见很好，基本就是小修。 2月11再次上传修改稿， 3月8号接受。一切很顺利。之前投稿Journal of Clinical Oncology，审稿人提了一堆与研究无关的审稿意见。于是索性原稿投Annals of Oncology。所幸中了。 , objectType=tool_impact_factor, channel=null, level=null, likeNumber=263, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://cdnapi.center.medsci.cn/medsci/head/2017/08/15/af911bdd940ac5430dfecaae1ba3bfff.jpg, createdBy=75e41936661, createdName=sunliang, createdTime=Fri Apr 19 00:00:00 CST 2019, time=2019-04-19, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=586765, encodeId=c2d7586e65c3, content=2月3号修回。 3月16号接受。 187****8818暂无昵称 2020-01-08 发表:: 接收率：约25% 审稿时间：约1个月有一篇7天后被拒，没送审。另外一篇12月12投稿。 1月8号有反馈。目前小修。187****8818暂无昵称 2020-01-08 00:00:00 发表: 有一篇7天后被拒，没送审。另外一篇12月12投稿。 1月8号有反馈。目前小修。, beContent=187****8818暂无昵称 2020-01-08 发表:: 接收率：约25% 审稿时间：约1个月有一篇7天后被拒，没送审。另外一篇12月12投稿。 1月8号有反馈。目前小修。, objectType=tool_impact_factor, channel=null, level=null, likeNumber=262, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=d0805157601, createdName=146academ18暂无昵称, createdTime=Tue Mar 17 00:00:00 CST 2020, time=2020-03-17, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2148450, encodeId=4ab0214845062, content=审稿速度:3.0 | 投稿命中率:25.0 偏重的研究方向：肿瘤 经验分享：为什么现在首页打不开, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=167, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=1f218759120, createdName=ms3000001014938846, createdTime=Mon Jul 17 14:52:01 CST 2023, time=2023-07-17, status=1, ipAttribution=天津), GetPortalCommentsPageByObjectIdResponse(id=567781, encodeId=039656e78139, content=为什么现在杂志投稿连接打不开, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=307, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=d09f88778, createdName=wwei0125, createdTime=Thu Mar 07 19:24:00 CST 2019, time=2019-03-07, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=881986, encodeId=082b8819863d, content=不接受非邀稿的综述，两个小时秒拒, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=347, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://wx.qlogo.cn/mmopen/vi_32/Q0gbVISGnicok3a1pkk9eJjGUG8JvN5oCPbpgzZ0gK3jcOMeNDmiajAUNfvf1vrSzgFDoKdibR60zVzdpBxBOs9cw/0, createdBy=83c82193682, createdName=krygios, createdTime=Wed Sep 02 07:27:09 CST 2020, time=2020-09-02, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=587926, encodeId=81dd58e92619, content=大家有没有注意自己的投稿状态呀？Under review指的是还在编辑手上评估吗？还是说和其他期刊的Under Review 一样，已经送外审了呢？知道投稿状态的请教一下。谢谢。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=372, replyNumber=6, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=10ee2307349, createdName=1221c8e5m44(暂无昵称), createdTime=Wed Apr 01 00:00:00 CST 2020, time=2020-04-01, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1086767, encodeId=c65a1086e6759, content=什么是letter?, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=215, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20220301/3a52d3952dde49019f1e000bb5c41d1c/0a0eb7959bb14fcd87745f869bee3c33.jpg, createdBy=46f32239729, createdName=Mia, createdTime=Tue Dec 28 14:52:47 CST 2021, time=2021-12-28, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1086768, encodeId=b5e91086e6834, content=什么是comment？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=206, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20220301/3a52d3952dde49019f1e000bb5c41d1c/0a0eb7959bb14fcd87745f869bee3c33.jpg, createdBy=46f32239729, createdName=Mia, createdTime=Mon Dec 27 14:52:47 CST 2021, time=2021-12-27, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=900668, encodeId=0036900668be, content=接受基础文章吗, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=347, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/Q0j4TwGTfTJYzYwLeVAa37S42RVHfvKoq2bVFKkmib0QsicMXN2gLlLkOrvs7ndVfL4IosDDSX4DibicGUhGVgmlYA/132, createdBy=b99e2511660, createdName=大医wgz, createdTime=Fri Nov 20 00:36:40 CST 2020, time=2020-11-20, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=885313, encodeId=22e1885313e9, content=想问一下under review 是送审了吗？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=343, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f6ed5410581, createdName=ms6000001824280640, createdTime=Mon Sep 14 23:14:22 CST 2020, time=2020-09-14, status=1, ipAttribution=)]

2020-04-01 1221c8e5m44(暂无昵称)

大家有没有注意自己的投稿状态呀？Under review指的是还在编辑手上评估吗？还是说和其他期刊的Under Review 一样，已经送外审了呢？知道投稿状态的请教一下。谢谢。

372 6

展开6条回复

[GetPortalCommentsPageByObjectIdResponse(id=569761, encodeId=f286569e6195, content=那也不错了啊！Dr_Hemis_AI 2019-03-09 发表:: 审稿意见很好，基本就是小修。 2月11再次上传修改稿， 3月8号接受。一切很顺利。之前投稿Journal of Clinical Oncology，审稿人提了一堆与研究无关的审稿意见。于是索性原稿投Annals of Oncology。所幸中了。 Dr_Hemis_AI 2019-03-09 00:00:00 发表: 审稿意见很好，基本就是小修。 2月11再次上传修改稿， 3月8号接受。一切很顺利。之前投稿Journal of Clinical Oncology，审稿人提了一堆与研究无关的审稿意见。于是索性原稿投Annals of Oncology。所幸中了。 , beContent=Dr_Hemis_AI 2019-03-09 发表:: 审稿意见很好，基本就是小修。 2月11再次上传修改稿， 3月8号接受。一切很顺利。之前投稿Journal of Clinical Oncology，审稿人提了一堆与研究无关的审稿意见。于是索性原稿投Annals of Oncology。所幸中了。 , objectType=tool_impact_factor, channel=null, level=null, likeNumber=263, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://cdnapi.center.medsci.cn/medsci/head/2017/08/15/af911bdd940ac5430dfecaae1ba3bfff.jpg, createdBy=75e41936661, createdName=sunliang, createdTime=Fri Apr 19 00:00:00 CST 2019, time=2019-04-19, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=586765, encodeId=c2d7586e65c3, content=2月3号修回。 3月16号接受。 187****8818暂无昵称 2020-01-08 发表:: 接收率：约25% 审稿时间：约1个月有一篇7天后被拒，没送审。另外一篇12月12投稿。 1月8号有反馈。目前小修。187****8818暂无昵称 2020-01-08 00:00:00 发表: 有一篇7天后被拒，没送审。另外一篇12月12投稿。 1月8号有反馈。目前小修。, beContent=187****8818暂无昵称 2020-01-08 发表:: 接收率：约25% 审稿时间：约1个月有一篇7天后被拒，没送审。另外一篇12月12投稿。 1月8号有反馈。目前小修。, objectType=tool_impact_factor, channel=null, level=null, likeNumber=262, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=d0805157601, createdName=146academ18暂无昵称, createdTime=Tue Mar 17 00:00:00 CST 2020, time=2020-03-17, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2148450, encodeId=4ab0214845062, content=审稿速度:3.0 | 投稿命中率:25.0 偏重的研究方向：肿瘤 经验分享：为什么现在首页打不开, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=167, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=1f218759120, createdName=ms3000001014938846, createdTime=Mon Jul 17 14:52:01 CST 2023, time=2023-07-17, status=1, ipAttribution=天津), GetPortalCommentsPageByObjectIdResponse(id=567781, encodeId=039656e78139, content=为什么现在杂志投稿连接打不开, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=307, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=d09f88778, createdName=wwei0125, createdTime=Thu Mar 07 19:24:00 CST 2019, time=2019-03-07, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=881986, encodeId=082b8819863d, content=不接受非邀稿的综述，两个小时秒拒, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=347, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://wx.qlogo.cn/mmopen/vi_32/Q0gbVISGnicok3a1pkk9eJjGUG8JvN5oCPbpgzZ0gK3jcOMeNDmiajAUNfvf1vrSzgFDoKdibR60zVzdpBxBOs9cw/0, createdBy=83c82193682, createdName=krygios, createdTime=Wed Sep 02 07:27:09 CST 2020, time=2020-09-02, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=587926, encodeId=81dd58e92619, content=大家有没有注意自己的投稿状态呀？Under review指的是还在编辑手上评估吗？还是说和其他期刊的Under Review 一样，已经送外审了呢？知道投稿状态的请教一下。谢谢。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=372, replyNumber=6, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=10ee2307349, createdName=1221c8e5m44(暂无昵称), createdTime=Wed Apr 01 00:00:00 CST 2020, time=2020-04-01, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1086767, encodeId=c65a1086e6759, content=什么是letter?, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=215, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20220301/3a52d3952dde49019f1e000bb5c41d1c/0a0eb7959bb14fcd87745f869bee3c33.jpg, createdBy=46f32239729, createdName=Mia, createdTime=Tue Dec 28 14:52:47 CST 2021, time=2021-12-28, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1086768, encodeId=b5e91086e6834, content=什么是comment？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=206, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20220301/3a52d3952dde49019f1e000bb5c41d1c/0a0eb7959bb14fcd87745f869bee3c33.jpg, createdBy=46f32239729, createdName=Mia, createdTime=Mon Dec 27 14:52:47 CST 2021, time=2021-12-27, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=900668, encodeId=0036900668be, content=接受基础文章吗, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=347, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/Q0j4TwGTfTJYzYwLeVAa37S42RVHfvKoq2bVFKkmib0QsicMXN2gLlLkOrvs7ndVfL4IosDDSX4DibicGUhGVgmlYA/132, createdBy=b99e2511660, createdName=大医wgz, createdTime=Fri Nov 20 00:36:40 CST 2020, time=2020-11-20, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=885313, encodeId=22e1885313e9, content=想问一下under review 是送审了吗？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=343, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f6ed5410581, createdName=ms6000001824280640, createdTime=Mon Sep 14 23:14:22 CST 2020, time=2020-09-14, status=1, ipAttribution=)]

2021-12-28 Mia

什么是letter?

215 1

展开1条回复

[GetPortalCommentsPageByObjectIdResponse(id=569761, encodeId=f286569e6195, content=那也不错了啊！Dr_Hemis_AI 2019-03-09 发表:: 审稿意见很好，基本就是小修。 2月11再次上传修改稿， 3月8号接受。一切很顺利。之前投稿Journal of Clinical Oncology，审稿人提了一堆与研究无关的审稿意见。于是索性原稿投Annals of Oncology。所幸中了。 Dr_Hemis_AI 2019-03-09 00:00:00 发表: 审稿意见很好，基本就是小修。 2月11再次上传修改稿， 3月8号接受。一切很顺利。之前投稿Journal of Clinical Oncology，审稿人提了一堆与研究无关的审稿意见。于是索性原稿投Annals of Oncology。所幸中了。 , beContent=Dr_Hemis_AI 2019-03-09 发表:: 审稿意见很好，基本就是小修。 2月11再次上传修改稿， 3月8号接受。一切很顺利。之前投稿Journal of Clinical Oncology，审稿人提了一堆与研究无关的审稿意见。于是索性原稿投Annals of Oncology。所幸中了。 , objectType=tool_impact_factor, channel=null, level=null, likeNumber=263, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://cdnapi.center.medsci.cn/medsci/head/2017/08/15/af911bdd940ac5430dfecaae1ba3bfff.jpg, createdBy=75e41936661, createdName=sunliang, createdTime=Fri Apr 19 00:00:00 CST 2019, time=2019-04-19, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=586765, encodeId=c2d7586e65c3, content=2月3号修回。 3月16号接受。 187****8818暂无昵称 2020-01-08 发表:: 接收率：约25% 审稿时间：约1个月有一篇7天后被拒，没送审。另外一篇12月12投稿。 1月8号有反馈。目前小修。187****8818暂无昵称 2020-01-08 00:00:00 发表: 有一篇7天后被拒，没送审。另外一篇12月12投稿。 1月8号有反馈。目前小修。, beContent=187****8818暂无昵称 2020-01-08 发表:: 接收率：约25% 审稿时间：约1个月有一篇7天后被拒，没送审。另外一篇12月12投稿。 1月8号有反馈。目前小修。, objectType=tool_impact_factor, channel=null, level=null, likeNumber=262, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=d0805157601, createdName=146academ18暂无昵称, createdTime=Tue Mar 17 00:00:00 CST 2020, time=2020-03-17, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2148450, encodeId=4ab0214845062, content=审稿速度:3.0 | 投稿命中率:25.0 偏重的研究方向：肿瘤 经验分享：为什么现在首页打不开, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=167, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=1f218759120, createdName=ms3000001014938846, createdTime=Mon Jul 17 14:52:01 CST 2023, time=2023-07-17, status=1, ipAttribution=天津), GetPortalCommentsPageByObjectIdResponse(id=567781, encodeId=039656e78139, content=为什么现在杂志投稿连接打不开, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=307, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=d09f88778, createdName=wwei0125, createdTime=Thu Mar 07 19:24:00 CST 2019, time=2019-03-07, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=881986, encodeId=082b8819863d, content=不接受非邀稿的综述，两个小时秒拒, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=347, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://wx.qlogo.cn/mmopen/vi_32/Q0gbVISGnicok3a1pkk9eJjGUG8JvN5oCPbpgzZ0gK3jcOMeNDmiajAUNfvf1vrSzgFDoKdibR60zVzdpBxBOs9cw/0, createdBy=83c82193682, createdName=krygios, createdTime=Wed Sep 02 07:27:09 CST 2020, time=2020-09-02, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=587926, encodeId=81dd58e92619, content=大家有没有注意自己的投稿状态呀？Under review指的是还在编辑手上评估吗？还是说和其他期刊的Under Review 一样，已经送外审了呢？知道投稿状态的请教一下。谢谢。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=372, replyNumber=6, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=10ee2307349, createdName=1221c8e5m44(暂无昵称), createdTime=Wed Apr 01 00:00:00 CST 2020, time=2020-04-01, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1086767, encodeId=c65a1086e6759, content=什么是letter?, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=215, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20220301/3a52d3952dde49019f1e000bb5c41d1c/0a0eb7959bb14fcd87745f869bee3c33.jpg, createdBy=46f32239729, createdName=Mia, createdTime=Tue Dec 28 14:52:47 CST 2021, time=2021-12-28, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1086768, encodeId=b5e91086e6834, content=什么是comment？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=206, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20220301/3a52d3952dde49019f1e000bb5c41d1c/0a0eb7959bb14fcd87745f869bee3c33.jpg, createdBy=46f32239729, createdName=Mia, createdTime=Mon Dec 27 14:52:47 CST 2021, time=2021-12-27, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=900668, encodeId=0036900668be, content=接受基础文章吗, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=347, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/Q0j4TwGTfTJYzYwLeVAa37S42RVHfvKoq2bVFKkmib0QsicMXN2gLlLkOrvs7ndVfL4IosDDSX4DibicGUhGVgmlYA/132, createdBy=b99e2511660, createdName=大医wgz, createdTime=Fri Nov 20 00:36:40 CST 2020, time=2020-11-20, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=885313, encodeId=22e1885313e9, content=想问一下under review 是送审了吗？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=343, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f6ed5410581, createdName=ms6000001824280640, createdTime=Mon Sep 14 23:14:22 CST 2020, time=2020-09-14, status=1, ipAttribution=)]

2021-12-27 Mia

什么是comment？

206 1

展开1条回复

[GetPortalCommentsPageByObjectIdResponse(id=569761, encodeId=f286569e6195, content=那也不错了啊！Dr_Hemis_AI 2019-03-09 发表:: 审稿意见很好，基本就是小修。 2月11再次上传修改稿， 3月8号接受。一切很顺利。之前投稿Journal of Clinical Oncology，审稿人提了一堆与研究无关的审稿意见。于是索性原稿投Annals of Oncology。所幸中了。 Dr_Hemis_AI 2019-03-09 00:00:00 发表: 审稿意见很好，基本就是小修。 2月11再次上传修改稿， 3月8号接受。一切很顺利。之前投稿Journal of Clinical Oncology，审稿人提了一堆与研究无关的审稿意见。于是索性原稿投Annals of Oncology。所幸中了。 , beContent=Dr_Hemis_AI 2019-03-09 发表:: 审稿意见很好，基本就是小修。 2月11再次上传修改稿， 3月8号接受。一切很顺利。之前投稿Journal of Clinical Oncology，审稿人提了一堆与研究无关的审稿意见。于是索性原稿投Annals of Oncology。所幸中了。 , objectType=tool_impact_factor, channel=null, level=null, likeNumber=263, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://cdnapi.center.medsci.cn/medsci/head/2017/08/15/af911bdd940ac5430dfecaae1ba3bfff.jpg, createdBy=75e41936661, createdName=sunliang, createdTime=Fri Apr 19 00:00:00 CST 2019, time=2019-04-19, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=586765, encodeId=c2d7586e65c3, content=2月3号修回。 3月16号接受。 187****8818暂无昵称 2020-01-08 发表:: 接收率：约25% 审稿时间：约1个月有一篇7天后被拒，没送审。另外一篇12月12投稿。 1月8号有反馈。目前小修。187****8818暂无昵称 2020-01-08 00:00:00 发表: 有一篇7天后被拒，没送审。另外一篇12月12投稿。 1月8号有反馈。目前小修。, beContent=187****8818暂无昵称 2020-01-08 发表:: 接收率：约25% 审稿时间：约1个月有一篇7天后被拒，没送审。另外一篇12月12投稿。 1月8号有反馈。目前小修。, objectType=tool_impact_factor, channel=null, level=null, likeNumber=262, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=d0805157601, createdName=146academ18暂无昵称, createdTime=Tue Mar 17 00:00:00 CST 2020, time=2020-03-17, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2148450, encodeId=4ab0214845062, content=审稿速度:3.0 | 投稿命中率:25.0 偏重的研究方向：肿瘤 经验分享：为什么现在首页打不开, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=167, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=1f218759120, createdName=ms3000001014938846, createdTime=Mon Jul 17 14:52:01 CST 2023, time=2023-07-17, status=1, ipAttribution=天津), GetPortalCommentsPageByObjectIdResponse(id=567781, encodeId=039656e78139, content=为什么现在杂志投稿连接打不开, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=307, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=d09f88778, createdName=wwei0125, createdTime=Thu Mar 07 19:24:00 CST 2019, time=2019-03-07, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=881986, encodeId=082b8819863d, content=不接受非邀稿的综述，两个小时秒拒, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=347, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://wx.qlogo.cn/mmopen/vi_32/Q0gbVISGnicok3a1pkk9eJjGUG8JvN5oCPbpgzZ0gK3jcOMeNDmiajAUNfvf1vrSzgFDoKdibR60zVzdpBxBOs9cw/0, createdBy=83c82193682, createdName=krygios, createdTime=Wed Sep 02 07:27:09 CST 2020, time=2020-09-02, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=587926, encodeId=81dd58e92619, content=大家有没有注意自己的投稿状态呀？Under review指的是还在编辑手上评估吗？还是说和其他期刊的Under Review 一样，已经送外审了呢？知道投稿状态的请教一下。谢谢。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=372, replyNumber=6, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=10ee2307349, createdName=1221c8e5m44(暂无昵称), createdTime=Wed Apr 01 00:00:00 CST 2020, time=2020-04-01, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1086767, encodeId=c65a1086e6759, content=什么是letter?, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=215, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20220301/3a52d3952dde49019f1e000bb5c41d1c/0a0eb7959bb14fcd87745f869bee3c33.jpg, createdBy=46f32239729, createdName=Mia, createdTime=Tue Dec 28 14:52:47 CST 2021, time=2021-12-28, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1086768, encodeId=b5e91086e6834, content=什么是comment？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=206, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20220301/3a52d3952dde49019f1e000bb5c41d1c/0a0eb7959bb14fcd87745f869bee3c33.jpg, createdBy=46f32239729, createdName=Mia, createdTime=Mon Dec 27 14:52:47 CST 2021, time=2021-12-27, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=900668, encodeId=0036900668be, content=接受基础文章吗, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=347, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/Q0j4TwGTfTJYzYwLeVAa37S42RVHfvKoq2bVFKkmib0QsicMXN2gLlLkOrvs7ndVfL4IosDDSX4DibicGUhGVgmlYA/132, createdBy=b99e2511660, createdName=大医wgz, createdTime=Fri Nov 20 00:36:40 CST 2020, time=2020-11-20, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=885313, encodeId=22e1885313e9, content=想问一下under review 是送审了吗？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=343, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f6ed5410581, createdName=ms6000001824280640, createdTime=Mon Sep 14 23:14:22 CST 2020, time=2020-09-14, status=1, ipAttribution=)]

2020-11-20 大医wgz

接受基础文章吗

347 2

展开2条回复

[GetPortalCommentsPageByObjectIdResponse(id=569761, encodeId=f286569e6195, content=那也不错了啊！Dr_Hemis_AI 2019-03-09 发表:: 审稿意见很好，基本就是小修。 2月11再次上传修改稿， 3月8号接受。一切很顺利。之前投稿Journal of Clinical Oncology，审稿人提了一堆与研究无关的审稿意见。于是索性原稿投Annals of Oncology。所幸中了。 Dr_Hemis_AI 2019-03-09 00:00:00 发表: 审稿意见很好，基本就是小修。 2月11再次上传修改稿， 3月8号接受。一切很顺利。之前投稿Journal of Clinical Oncology，审稿人提了一堆与研究无关的审稿意见。于是索性原稿投Annals of Oncology。所幸中了。 , beContent=Dr_Hemis_AI 2019-03-09 发表:: 审稿意见很好，基本就是小修。 2月11再次上传修改稿， 3月8号接受。一切很顺利。之前投稿Journal of Clinical Oncology，审稿人提了一堆与研究无关的审稿意见。于是索性原稿投Annals of Oncology。所幸中了。 , objectType=tool_impact_factor, channel=null, level=null, likeNumber=263, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://cdnapi.center.medsci.cn/medsci/head/2017/08/15/af911bdd940ac5430dfecaae1ba3bfff.jpg, createdBy=75e41936661, createdName=sunliang, createdTime=Fri Apr 19 00:00:00 CST 2019, time=2019-04-19, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=586765, encodeId=c2d7586e65c3, content=2月3号修回。 3月16号接受。 187****8818暂无昵称 2020-01-08 发表:: 接收率：约25% 审稿时间：约1个月有一篇7天后被拒，没送审。另外一篇12月12投稿。 1月8号有反馈。目前小修。187****8818暂无昵称 2020-01-08 00:00:00 发表: 有一篇7天后被拒，没送审。另外一篇12月12投稿。 1月8号有反馈。目前小修。, beContent=187****8818暂无昵称 2020-01-08 发表:: 接收率：约25% 审稿时间：约1个月有一篇7天后被拒，没送审。另外一篇12月12投稿。 1月8号有反馈。目前小修。, objectType=tool_impact_factor, channel=null, level=null, likeNumber=262, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=d0805157601, createdName=146academ18暂无昵称, createdTime=Tue Mar 17 00:00:00 CST 2020, time=2020-03-17, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2148450, encodeId=4ab0214845062, content=审稿速度:3.0 | 投稿命中率:25.0 偏重的研究方向：肿瘤 经验分享：为什么现在首页打不开, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=167, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=1f218759120, createdName=ms3000001014938846, createdTime=Mon Jul 17 14:52:01 CST 2023, time=2023-07-17, status=1, ipAttribution=天津), GetPortalCommentsPageByObjectIdResponse(id=567781, encodeId=039656e78139, content=为什么现在杂志投稿连接打不开, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=307, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=d09f88778, createdName=wwei0125, createdTime=Thu Mar 07 19:24:00 CST 2019, time=2019-03-07, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=881986, encodeId=082b8819863d, content=不接受非邀稿的综述，两个小时秒拒, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=347, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://wx.qlogo.cn/mmopen/vi_32/Q0gbVISGnicok3a1pkk9eJjGUG8JvN5oCPbpgzZ0gK3jcOMeNDmiajAUNfvf1vrSzgFDoKdibR60zVzdpBxBOs9cw/0, createdBy=83c82193682, createdName=krygios, createdTime=Wed Sep 02 07:27:09 CST 2020, time=2020-09-02, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=587926, encodeId=81dd58e92619, content=大家有没有注意自己的投稿状态呀？Under review指的是还在编辑手上评估吗？还是说和其他期刊的Under Review 一样，已经送外审了呢？知道投稿状态的请教一下。谢谢。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=372, replyNumber=6, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=10ee2307349, createdName=1221c8e5m44(暂无昵称), createdTime=Wed Apr 01 00:00:00 CST 2020, time=2020-04-01, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1086767, encodeId=c65a1086e6759, content=什么是letter?, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=215, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20220301/3a52d3952dde49019f1e000bb5c41d1c/0a0eb7959bb14fcd87745f869bee3c33.jpg, createdBy=46f32239729, createdName=Mia, createdTime=Tue Dec 28 14:52:47 CST 2021, time=2021-12-28, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1086768, encodeId=b5e91086e6834, content=什么是comment？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=206, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20220301/3a52d3952dde49019f1e000bb5c41d1c/0a0eb7959bb14fcd87745f869bee3c33.jpg, createdBy=46f32239729, createdName=Mia, createdTime=Mon Dec 27 14:52:47 CST 2021, time=2021-12-27, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=900668, encodeId=0036900668be, content=接受基础文章吗, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=347, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/Q0j4TwGTfTJYzYwLeVAa37S42RVHfvKoq2bVFKkmib0QsicMXN2gLlLkOrvs7ndVfL4IosDDSX4DibicGUhGVgmlYA/132, createdBy=b99e2511660, createdName=大医wgz, createdTime=Fri Nov 20 00:36:40 CST 2020, time=2020-11-20, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=885313, encodeId=22e1885313e9, content=想问一下under review 是送审了吗？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=343, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f6ed5410581, createdName=ms6000001824280640, createdTime=Mon Sep 14 23:14:22 CST 2020, time=2020-09-14, status=1, ipAttribution=)]

2020-09-14 ms6000001824280640

想问一下under review 是送审了吗？

343 2

展开2条回复

内科

外科

专科科室

热点

按科室浏览

临床工具

科研工具

其他工具

科研数智化

真实世界研究解决方案

数字化学术传播解决方案

其它

期刊讨论

科室

工具

服务